Top

Published in:

Open Access 01-09-2019 | Human Papillomavirus | General Gynecology

Recurrence of genitals warts in pre-HPV vaccine era after laser treatment

Authors: Andreas Widschwendter, Bettina Böttcher, David Riedl, Serab Coban, Irene Mutz-Dehbalaie, Raffaella Matteucci Gothe, Alexandra Ciresa-König, Christian Marth, Siegfried Fessler

Published in: Archives of Gynecology and Obstetrics | Issue 3/2019

Abstract

Purpose

Human papillomavirus (HPV) can cause condylomata acuminata, also known as genital warts. Our aim was to evaluate the long-term recurrence of genital warts after primary carbon dioxide laser treatment before the introduction of the vaccination against HPV.

Methods

Recurrence rate and localization of genital warts were analysed in a retrospective study in 1798 women presenting with a new diagnosis of genital warts from 1992 to 2009 at a University hospital and had received laser treatment. Additionally, data on topography, pregnancy status, and cervical smear were available for women treated from 2003 to 2009 (n = 825, data subset 1) and systematic follow-up data for women treated in 2006 and 2007 (n = 242, data subset 2).

Results

Median time from laser treatment to first recurrence was 14.6 weeks (data subset 2). The site most affected was the vulva (90.7%) followed by the perineum/perianal region (59.3%) and the vagina (47.3%). Abnormal Pap smear was observed in 22.6%. Systematic follow-up with a median follow-up time of 3.1 years revealed at least one recurrence in 68 (28.1%) of 242 women. Women with multifocal genital warts had a 2.9 times increased risk for recurrence compared to women with unifocal lesions (p = 0.01).

Conclusions

Nearly 30% of women presenting with genital warts experienced at least one recurrence after treatment with carbon dioxide laser. Multifocal lesions are the strongest indicator of recurrence. These data provide an important insight to recurrence rates of genital warts before HPV vaccination and underline the significance of a long-term follow-up and HPV vaccination.

Brown DR, Schroeder JM, Bryan JT et al (1999) Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J Clin Microbiol 37:3316–3322PubMedPubMedCentral

Garland SM, Steben M, Sings HL et al (2009) Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis 199:805–814. https://doi.org/10.1086/597071 CrossRefPubMed

Wiley DJ, Douglas J, Beutner K et al (2002) External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis 35:S210–S224. https://doi.org/10.1086/342109 CrossRefPubMed

Hillemanns P, Breugelmans JG, Gieseking F et al (2008) Estimation of the incidence of genital warts and the cost of illness in Germany: a cross-sectional study. BMC Infect Dis 8:76. https://doi.org/10.1186/1471-2334-8-76 CrossRefPubMedPubMedCentral

Kliewer EV, Demers AA, Elliott L et al (2009) Twenty-year trends in the incidence and prevalence of diagnosed anogenital warts in Canada. Sex Transm Dis 36:380–386. https://doi.org/10.1097/OLQ.0b013e318198de8c CrossRefPubMed

Saslow D, Andrews KS, Manassaram-Baptiste D et al (2016) Human papillomavirus vaccination guideline update: American Cancer Society guideline endorsement. CA Cancer J Clin 66:375–385. https://doi.org/10.3322/caac.21355 CrossRefPubMedPubMedCentral

Kjaer SK, Tran TN, Sparen P et al (2007) The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis 196:1447–1454. https://doi.org/10.1086/522863 CrossRefPubMed

Wiley D, Masongsong E (2006) Human papillomavirus: the burden of infection. Obstet Gynecol Surv 61:S3–14. https://doi.org/10.1097/01.ogx.0000221010.82943.8c CrossRefPubMed

Dominiak-Felden G, Cohet C, Atrux-Tallau S et al (2013) Impact of human papillomavirus-related genital diseases on quality of life and psychosocial wellbeing: results of an observational, health-related quality of life study in the UK. BMC Public Health 13:1065. https://doi.org/10.1186/1471-2458-13-1065 CrossRefPubMedPubMedCentral

10.

Paradisi A, Capizzi R, Ricci F et al (2013) Quality of life in patients with anogenital warts. Eur J Dermatol 23:837–842. https://doi.org/10.1684/ejd.2013.2171 CrossRefPubMed

11.

Jeynes C, Chung MC, Challenor R (2009) “Shame on you–”the psychosocial impact of genital warts. Int J STD AIDS 20:557–560. https://doi.org/10.1258/ijsa.2008.008412 CrossRefPubMed

12.

Park IU, Introcaso C, Dunne EF (2015) Human papillomavirus and genital warts: a review of the evidence for the 2015 centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis 61(Suppl 8):S849–S855. https://doi.org/10.1093/cid/civ813 CrossRefPubMed

13.

Scheinfeld N, Lehman DS (2006) An evidence-based review of medical and surgical treatments of genital warts. Dermatol Online J 12:5PubMed

14.

Lacey CJN, Woodhall SC, Wikstrom A, Ross J (2013) 2012 European guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol 27:e263–e270. https://doi.org/10.1111/j.1468-3083.2012.04493.x CrossRefPubMed

15.

Savoca S, Nardo LG, Rosano TF et al (2001) CO(2) laser vaporization as primary therapy for human papillomavirus lesions. A prospective observational study. Acta Obstet Gynecol Scand 80:1121–1124PubMed

16.

Duus BR, Philipsen T, Christensen JD et al (1985) Refractory condylomata acuminata: a controlled clinical trial of carbon dioxide laser versus conventional surgical treatment. Genitourin Med 61:59–61PubMedPubMedCentral

17.

Chen K, Chang BZ, Ju M et al (2007) Comparative study of photodynamic therapy vs CO2 laser vaporization in treatment of condylomata acuminata: a randomized clinical trial. Br J Dermatol 156:516–520. https://doi.org/10.1111/j.1365-2133.2006.07648.x CrossRefPubMed

18.

Aynaud O, Buffet M, Roman P et al (2008) Study of persistence and recurrence rates in 106 patients with condyloma and intraepithelial neoplasia after CO2 laser treatment. Eur J Dermatol 18:153–158. https://doi.org/10.1684/ejd.2008.0353 CrossRefPubMed

19.

Ferenczy A, Behelak Y, Haber G et al (1995) Treating vaginal and external anogenital condylomas with electrosurgery vs CO2 laser ablation. J Gynecol Surg 11:41–50. https://doi.org/10.1089/gyn.1995.11.41 CrossRefPubMed

20.

Krebs HB, Wheelock JB (1985) The CO2 laser for recurrent and therapy-resistant condylomata acuminata. J Reprod Med 30:489–492PubMed

21.

Thomas R, Steben M, Greenwald Z et al (2017) Recurrence of human papillomavirus external genital wart infection among high-risk adults in Montréal, Canada. Sex Transm Dis 44:700–706. https://doi.org/10.1097/OLQ.0000000000000666 CrossRefPubMed

22.

Ali H, Donovan B, Wand H et al (2013) Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ 346:f2032–f2032. https://doi.org/10.1136/bmj.f2032 CrossRefPubMed

23.

Drolet M, Bénard É, Boily M-C et al (2015) Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 15:565–580. https://doi.org/10.1016/S1473-3099(14)71073-4 CrossRefPubMedPubMedCentral

24.

Soost HJ (1993) The Munich nomenclature. Recent Results Cancer Res 133:105–111CrossRefPubMed

25.

Habel LA, Van Den Eeden SK, Sherman KJ et al (1998) Risk factors for incident and recurrent condylomata acuminata among women. A population-based study. Sex Transm Dis 25:285–292CrossRefPubMed

26.

Munk C, Svare EI, Poll P et al (1997) History of genital warts in 10,838 women 20 to 29 years of age from the general population. Risk factors and association with Papanicolaou smear history. Sex Transm Dis 24:567–572CrossRefPubMed

27.

Drolet M, Laprise J-F, Brotherton JML et al (2017) The impact of human papillomavirus catch-up vaccination in Australia: implications for introduction of multiple age cohort vaccination and postvaccination data interpretation. J Infect Dis 216:1205–1209. https://doi.org/10.1093/infdis/jix476 CrossRefPubMedPubMedCentral

28.

Friis S, Kjaer SK, Frisch M et al (1997) Cervical intraepithelial neoplasia, anogenital cancer, and other cancer types in women after hospitalization for condylomata acuminata. J Infect Dis 175:743–748CrossRefPubMed

29.

Ferenczy A (1984) Treating genital condyloma during pregnancy with the carbon dioxide laser. Am J Obstet Gynecol 148:9–12CrossRefPubMed

30.

Silverberg MJ, Thorsen P, Lindeberg H et al (2003) Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 101:645–652PubMed

Title: Recurrence of genitals warts in pre-HPV vaccine era after laser treatment
Authors: Andreas Widschwendter
Bettina Böttcher
David Riedl
Serab Coban
Irene Mutz-Dehbalaie
Raffaella Matteucci Gothe
Alexandra Ciresa-König
Christian Marth
Siegfried Fessler
Publication date: 01-09-2019
Publisher: Springer Berlin Heidelberg
Keywords: Human Papillomavirus
CO2 Laser
Vaccination
Wart
Laser
Published in: Archives of Gynecology and Obstetrics / Issue 3/2019
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-019-05242-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Recurrence of genitals warts in pre-HPV vaccine era after laser treatment

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2019

Early predictive factors of single dose methotrexate outcome in patients with ectopic pregnancy

Diagnostic accuracy of preoperative 18F-FDG PET or PET/CT in detecting pelvic and para-aortic lymph node metastasis in patients with endometrial cancer: a systematic review and meta-analysis

Carpal tunnel syndrome during the third trimester of pregnancy: prevalence and risk factors

A nomogram for decision-making of completion surgery in endometrial cancer diagnosed after hysterectomy

Macrolide antibiotics roxithromycin vs. azithromycin for preterm premature rupture of membranes: a retrospective comparison

Scoring system for the prediction of the severity of placenta accrete spectrum in women with placenta previa: a prospective observational study